Pamela R. Demain
Director/Board Member at Prokaryotics, Inc.
Profile
Pamela R.
Demain is currently the Director & Vice President-Business Development at Prokaryotics, Inc. She is also currently the Vice President-Communications at Licensing Executives Society since 2011.
Previously, she worked as a Trustee at BioNJ, Inc.
Pamela R. Demain active positions
| Companies | Position | Start |
|---|---|---|
| Licensing Executives Society | Investor Relations Contact | - |
Prokaryotics, Inc.
 Prokaryotics, Inc. Pharmaceuticals: MajorHealth Technology Prokaryotics, Inc. operates as an antibacterial discovery organization. It develops, manufactures and commercializes pre-clinical assets and programs targeting both Gram-negative and Gram-positive bacteria. The company was founded by Terry Roemer and is headquartered in Union, NJ. | Director/Board Member | - |
Former positions of Pamela R. Demain
| Companies | Position | End |
|---|---|---|
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| Licensing Executives Society | |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Prokaryotics, Inc.
Prokaryotics, Inc. Pharmaceuticals: MajorHealth Technology Prokaryotics, Inc. operates as an antibacterial discovery organization. It develops, manufactures and commercializes pre-clinical assets and programs targeting both Gram-negative and Gram-positive bacteria. The company was founded by Terry Roemer and is headquartered in Union, NJ. | Health Technology |
- Stock Market
- Insiders
- Pamela R. Demain